ArticleJPRAS open2026
Pediatric septorhinoplasty: A cohort study utilizing the pediatric health information system (PHIS) database.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pediatric rhinoplasty and septoplasty are performed for both functional and reconstructive indications, including airway obstruction, trauma, and orofacial cleft (OFC)-associated nasal deformities. Despite increasing national case volume, limited data exist on utilization patterns, procedural trends, and healthcare costs in this population. Methods: Using the Pediatric Health Information System (PHIS) database, we conducted a retrospective cohort study of patients 3-17 years old who underwent septoplasty, rhinoplasty, or septorhinoplasty between 2015 and 2022. Patients were stratified by OFC diagnosis and age group (3-14 vs. 15-17 years). Sub-analyses were performed for septoplasty-only and rhinoplasty/septorhinoplasty cohorts. Results: A total of 10,762 cases were identified; 24% had OFC. Septoplasty was nearly exclusive to non-cleft patients (98%) and increased with age, reflecting deferral until skeletal maturity. Septorhinoplasty showed a sharp volume increase after age 14, with earlier use in cleft patients as part of staged reconstruction. Graft use was significantly higher in OFC cases (21% vs. 5.5%, p < 0.0001), especially for auricular and dermal/fascial grafts. Turbinate reduction was more common in non-cleft patients. Complication and readmission rates were low across all groups (<2%). Total costs were higher in the OFC cohort but were comparable between cleft and non-cleft patients undergoing rhinoplasty/septorhinoplasty, suggesting procedure type was the primary cost driver. Conclusion: Pediatric septoplasty and rhinoplasty are safe, low-complication procedures across cleft and non-cleft populations. Trends reflect ongoing caution around timing of intervention, greater surgical complexity in cleft patients, and the need for standardized care pathways that balance functional, aesthetic, and developmental goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.